| KLARIA PHARMA HOLDING AB |
| Schweden |
| Gesundheit |
| SE0007280326 / A14V7P |
| 6FN (Frankfurt) |
| FRA:6FN, ETR:6FN, 6FN:GR |
| - |
| https://www.klaria.com/ |
|
Klaria Pharma Holding AB is a biopharmaceutical company that focuses on developing innovative therapies for the treatment of pain and urgent medical conditions. The company's primary function is to utilize its proprietary technology, which combines f..
>Volltext.. |
| 21.15 Mio. EUR |
| 21.12 Mio. EUR |
| 0.84 Mio. EUR |
| -1.31 Mio. EUR |
| -3.65 Mio. EUR |
| -0.02 EUR |
| - |
| 0.03 Mio. EUR |
| -3.28 Mio. EUR |
| 0.01 |
| 793.14% |
| 13.7% |
| - |
| - |
| - |
| - |
| KLARIA PHARMA |
| 05.04.26 |
|